AI Portfolio Summary
In 2025 Q4, Ikarian Capital, LLC maintained a portfolio of 236 distinct positions. The most significant new addition to the portfolio was CIDARA THERAPEUTICS , which now represents 5.17% of the total fund value. They heavily accumulated shares in SPDR SERIES TRUST, increasing their position by 13.3%. Conversely, Ikarian Capital, LLC completely exited their position in UNITED THERAPEUTICS .
Total Positions
236
Quarter
2025 Q4
Top Holding
XBI (8.1%)
Top 10 Concentration
38.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 236
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 8.09% | 7.59% |
#1
1
Prev: #2
|
7.2 | 100,000 | 13.3% |
P
S
|
850,000 | $103,640,500 |
$113.25
+6.1%
|
2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
CDTX
PUT
CIDARA THERAPEU...
|
PUT Option | 5.17% | — |
#2
Prev: #—
|
7.1 | 300,000 | no change |
NEW
|
300,000 | $66,267,000 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMGN
PUT
AMGEN INC
|
PUT Option | 5.11% | — |
#3
Prev: #—
|
6.5 | 200,000 | no change |
NEW
|
200,000 | $65,462,000 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 5.04% | 0.12% |
#4
112
Prev: #116
|
5.5 | 1,432,176 | 872.2% |
P
S
|
1,596,378 | $64,493,671 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CDTX
CIDARA THERAPEU...
|
Healthcare | 4.71% | 2.69% |
#5
3
Prev: #8
|
2.9 | -4,461 | -1.6% |
P
S
|
273,243 | $60,356,645 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
ABIVAX SA
|
Healthcare | 2.27% | 3.37% |
#6
1
Prev: #5
|
0.9 | -190,113 | -48.0% |
P
S
|
205,985 | $29,129,537 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CALL
JAZZ PHARMACEUT...
|
—
|
CALL Option | 2.26% | 0.94% |
#7
22
Prev: #29
|
3.9 | 99,300 | 140.5% |
P
S
|
170,000 | $28,900,000 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 2.13% | 1.04% |
#8
17
Prev: #25
|
3.9 | 82,567 | 106.1% |
P
S
|
160,367 | $27,262,390 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 2.09% | 1.94% |
#9
1
Prev: #10
|
1.3 | -96,145 | -13.0% |
P
S
|
644,680 | $26,709,093 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 1.99% | 0.15% |
#10
97
Prev: #107
|
3.8 | 58,010 | 203.0% |
P
S
|
86,581 | $25,518,884 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HROW
CALL
HARROW INC
|
CALL Option | 1.95% | 1.41% |
#11
4
Prev: #15
|
3.8 | 220,000 | 75.9% |
P
S
|
509,700 | $24,975,300 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLNO
CALL
SOLENO THERAPEU...
|
CALL Option | 1.91% | 1.20% |
#12
8
Prev: #20
|
3.8 | 352,800 | 200.3% |
P
S
|
528,900 | $24,488,070 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 1.76% | 1.60% |
#13
1
Prev: #12
|
2.7 | 50,271 | 8.2% |
P
S
|
665,271 | $22,532,728 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KOD
KODIAK SCIENCES...
|
Healthcare | 1.57% | 0.68% |
#14
21
Prev: #35
|
3.6 | 305,946 | 73.9% |
P
S
|
719,787 | $20,125,245 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 1.48% | — |
#15
Prev: #—
|
4.1 | 758,654 | no change |
NEW
|
758,654 | $18,966,350 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYTK
CALL
CYTOKINETICS IN...
|
CALL Option | 1.44% | 0.62% |
#16
22
Prev: #38
|
3.6 | 180,000 | 162.3% |
P
S
|
290,900 | $18,483,786 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 1.36% | 1.13% |
#17
5
Prev: #22
|
3.0 | 67,000 | 21.5% |
P
S
|
378,682 | $17,472,389 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRNX
PUT
CRINETICS PHARM...
|
PUT Option | 1.34% | — |
#18
Prev: #—
|
4.0 | 368,500 | no change |
NEW
|
368,500 | $17,153,675 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
CALL
ABIVAX SA
|
CALL Option | 1.32% | — |
#19
Prev: #—
|
4.0 | 125,100 | no change |
NEW
|
125,100 | $16,870,363 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAPR
CAPRICOR THERAP...
|
Healthcare | 1.30% | 0.19% |
#20
82
Prev: #102
|
3.5 | 313,373 | 118.4% |
P
S
|
578,015 | $16,681,512 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OMER
PUT
OMEROS CORP
|
PUT Option | 1.27% | — |
#21
Prev: #—
|
4.0 | 950,000 | no change |
NEW
|
950,000 | $16,316,252 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 1.25% | 2.74% |
#22
15
Prev: #7
|
0.5 | -213,125 | -51.3% |
P
S
|
202,038 | $15,983,226 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 1.21% | 1.20% |
#23
2
Prev: #21
|
2.5 | 86,247 | 6.7% |
P
S
|
1,375,472 | $15,556,588 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 1.16% | — |
#24
Prev: #—
|
4.0 | 13,815 | no change |
NEW
|
13,815 | $14,846,704 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RLMD
RELMADA THERAPE...
|
Healthcare | 1.16% | 0.37% |
#25
47
Prev: #72
|
3.5 | 1,225,299 | 66.5% |
P
S
|
3,068,359 | $14,820,175 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
PUT
UNITED THERAPEU...
|
PUT Option | 0.00% | 8.88% |
Sold All 😨
(Was: #1) |
0.0 | -209,800 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GMAB
GENMAB A/S
|
Healthcare | 0.00% | 5.35% |
Sold All 😨
(Was: #3) |
0.0 | -175,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BMY
PUT
BRISTOL-MYERS S...
|
PUT Option | 0.00% | 3.64% |
Sold All 😨
(Was: #4) |
0.0 | -800,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRRK
CALL
SCHOLAR ROCK HL...
|
CALL Option | 0.00% | 2.11% |
Sold All 😨
(Was: #9) |
0.0 | -561,600 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSM
PUT
INSMED INC
|
PUT Option | 0.00% | 1.45% |
Sold All 😨
(Was: #13) |
0.0 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 0.00% | 1.37% |
Sold All 😨
(Was: #16) |
0.0 | -346,001 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTCT
CALL
PTC THERAPEUTIC...
|
CALL Option | 0.00% | 1.32% |
Sold All 😨
(Was: #17) |
0.0 | -213,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CALL
BIOHAVEN LTD
|
—
|
CALL Option | 0.00% | 1.21% |
Sold All 😨
(Was: #19) |
0.0 | -796,400 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
CRNX
CALL
CRINETICS PHARM...
|
CALL Option | 0.00% | 1.08% |
Sold All 😨
(Was: #24) |
0.0 | -257,700 | -100.0% |
CLOSED
|
— | $— | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
AKERO THERAPEUT...
|
Healthcare | 0.00% | 0.99% |
Sold All 😨
(Was: #28) |
0.0 | -206,854 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NVO
CALL
NOVO-NORDISK A ...
|
CALL Option | 0.00% | 0.84% |
Sold All 😨
(Was: #31) |
0.0 | -150,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNTA
CALL
CENTESSA PHARMA...
|
CALL Option | 0.00% | 0.75% |
Sold All 😨
(Was: #33) |
0.0 | -307,700 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPRY
CALL
ARS PHARMACEUTI...
|
CALL Option | 0.00% | 0.57% |
Sold All 😨
(Was: #40) |
0.0 | -562,400 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 0.00% | 0.55% |
Sold All 😨
(Was: #41) |
0.0 | -130,902 | -100.0% |
CLOSED
|
— | $— | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRAX
CALL
PRAXIS PRECISIO...
|
CALL Option | 0.00% | 0.54% |
Sold All 😨
(Was: #42) |
0.0 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.00% | 0.53% |
Sold All 😨
(Was: #43) |
0.0 | -245,518 | -100.0% |
CLOSED
|
— | $— | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 0.00% | 0.52% |
Sold All 😨
(Was: #45) |
0.0 | -333,733 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANAB
CALL
ANAPTYSBIO INC
|
CALL Option | 0.00% | 0.50% |
Sold All 😨
(Was: #49) |
0.0 | -161,100 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANAB
PUT
ANAPTYSBIO INC
|
PUT Option | 0.00% | 0.50% |
Sold All 😨
(Was: #48) |
0.0 | -161,100 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KALV
CALL
KALVISTA PHARMA...
|
CALL Option | 0.00% | 0.49% |
Sold All 😨
(Was: #50) |
0.0 | -400,000 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 0.00% | 0.46% |
Sold All 😨
(Was: #53) |
0.0 | -190,781 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LQDA
CALL
LIQUIDIA CORPOR...
|
CALL Option | 0.00% | 0.46% |
Sold All 😨
(Was: #54) |
0.0 | -200,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MTSR
PUT
METSERA INC
|
PUT Option | 0.00% | 0.45% |
Sold All 😨
(Was: #57) |
0.0 | -86,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MTSR
CALL
METSERA INC
|
CALL Option | 0.00% | 0.45% |
Sold All 😨
(Was: #56) |
0.0 | -86,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLTX
CALL
MOONLAKE IMMUNO...
|
CALL Option | 0.00% | 0.44% |
Sold All 😨
(Was: #60) |
0.0 | -612,200 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARGX
ARGENX SE
|
Healthcare | 0.00% | 0.43% |
Sold All 😨
(Was: #63) |
0.0 | -5,942 | -100.0% |
CLOSED
|
— | $— | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARCT
CALL
ARCTURUS THERAP...
|
CALL Option | 0.00% | 0.42% |
Sold All 😨
(Was: #64) |
0.0 | -227,200 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 0.00% | 0.41% |
Sold All 😨
(Was: #66) |
0.0 | -64,746 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TEVA
CALL
TEVA PHARMACEUT...
|
CALL Option | 0.00% | 0.41% |
Sold All 😨
(Was: #67) |
0.0 | -200,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALT
CALL
ALTIMMUNE INC
|
CALL Option | 0.00% | 0.38% |
Sold All 😨
(Was: #69) |
0.0 | -1,000,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRRK
PUT
SCHOLAR ROCK HL...
|
PUT Option | 0.00% | 0.36% |
Sold All 😨
(Was: #73) |
0.0 | -96,200 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MBX
CALL
MBX BIOSCIENCES...
|
CALL Option | 0.00% | 0.35% |
Sold All 😨
(Was: #75) |
0.0 | -200,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MBX
PUT
MBX BIOSCIENCES...
|
PUT Option | 0.00% | 0.35% |
Sold All 😨
(Was: #74) |
0.0 | -200,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLNO
PUT
SOLENO THERAPEU...
|
PUT Option | 0.00% | 0.34% |
Sold All 😨
(Was: #78) |
0.0 | -50,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLTX
PUT
MOONLAKE IMMUNO...
|
PUT Option | 0.00% | 0.33% |
Sold All 😨
(Was: #79) |
0.0 | -450,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 0.00% | 0.32% |
Sold All 😨
(Was: #80) |
0.0 | -435,839 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UPB
UPSTREAM BIO IN...
|
Healthcare | 0.00% | 0.31% |
Sold All 😨
(Was: #82) |
0.0 | -161,113 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 0.00% | 0.27% |
Sold All 😨
(Was: #87) |
0.0 | -51,967 | -100.0% |
CLOSED
|
— | $— | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRPT
CALL
SAREPTA THERAPE...
|
CALL Option | 0.00% | 0.27% |
Sold All 😨
(Was: #88) |
0.0 | -137,000 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 0.00% | 0.25% |
Sold All 😨
(Was: #91) |
0.0 | -467,362 | -100.0% |
CLOSED
|
— | $— | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPS
CALL
COMPASS PATHWAY...
|
CALL Option | 0.00% | 0.23% |
Sold All 😨
(Was: #94) |
0.0 | -400,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
CALL
AKERO THERAPEUT...
|
CALL Option | 0.00% | 0.20% |
Sold All 😨
(Was: #100) |
0.0 | -41,600 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LRMR
CALL
LARIMAR THERAPE...
|
CALL Option | 0.00% | 0.18% |
Sold All 😨
(Was: #104) |
0.0 | -548,400 | -100.0% |
CLOSED
|
— | $— | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANAB
ANAPTYSBIO INC
|
Healthcare | 0.00% | 0.15% |
Sold All 😨
(Was: #108) |
0.0 | -48,410 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 0.00% | 0.15% |
Sold All 😨
(Was: #109) |
0.0 | -113,837 | -100.0% |
CLOSED
|
— | $— | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRME
PUT
PRIME MEDICINE ...
|
PUT Option | 0.00% | 0.14% |
Sold All 😨
(Was: #112) |
0.0 | -250,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRME
CALL
PRIME MEDICINE ...
|
CALL Option | 0.00% | 0.14% |
Sold All 😨
(Was: #111) |
0.0 | -250,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JANX
JANUX THERAPEUT...
|
Healthcare | 0.00% | 0.13% |
Sold All 😨
(Was: #113) |
0.0 | -54,691 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 0.00% | 0.13% |
Sold All 😨
(Was: #115) |
0.0 | -72,787 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IFRX
INFLARX NV
|
Healthcare | 0.00% | 0.10% |
Sold All 😨
(Was: #118) |
0.0 | -722,066 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
CALL
UNITED THERAPEU...
|
CALL Option | 0.00% | 0.10% |
Sold All 😨
(Was: #119) |
0.0 | -2,300 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 0.00% | 0.08% |
Sold All 😨
(Was: #123) |
0.0 | -48,071 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRME
PRIME MEDICINE ...
|
Healthcare | 0.00% | 0.08% |
Sold All 😨
(Was: #124) |
0.0 | -150,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TVRD
CALL
TVARDI THERAPEU...
|
CALL Option | 0.00% | 0.07% |
Sold All 😨
(Was: #127) |
0.0 | -19,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAPR
CALL
CAPRICOR THERAP...
|
CALL Option | 0.00% | 0.07% |
Sold All 😨
(Was: #129) |
0.0 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAPR
PUT
CAPRICOR THERAP...
|
PUT Option | 0.00% | 0.07% |
Sold All 😨
(Was: #130) |
0.0 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRBP
CALL
CORBUS PHARMACE...
|
CALL Option | 0.00% | 0.07% |
Sold All 😨
(Was: #133) |
0.0 | -54,800 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SONN
SONNET BIOTHERA...
|
Healthcare | 0.00% | 0.07% |
Sold All 😨
(Was: #134) |
0.0 | -150,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PCVX
CALL
VAXCYTE INC
|
CALL Option | 0.00% | 0.03% |
Sold All 😨
(Was: #147) |
0.0 | -7,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARCT
ARCTURUS THERAP...
|
Healthcare | 0.00% | 0.02% |
Sold All 😨
(Was: #153) |
0.0 | -10,721 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 0.00% | 0.02% |
Sold All 😨
(Was: #155) |
0.0 | -11,280 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
AETHLON MED INC
|
—
|
Unknown | 0.00% | 0.01% |
Sold All 😨
(Was: #162) |
0.0 | -153,659 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 236 holdings